Universe Pharmaceuticals
Financial ratios & Valuation

Historical Multiples (2018 – 2023)

2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
1.18K208.04207.8671.18-21.09-8.381.5271.18
Price/Sales ratio
314.8447.2751.1616.794.591.590.3716.79
Price/Book Value ratio
927.27126.8675.5213.673.961.300.2413.67
Price/Cash Flow ratio
2.01K118.98256.91-391.97-140.4546.111.881.88
Price/Free Cash Flow ratio
2.08K119.76259.10-51.69-131.0948.011.901.90
Price/Earnings Growth ratio
N/A0.44426.111.380.110.280.001.38
Dividend Yield
0.03%1.01%N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
47.02%40.34%45.90%52.78%54.53%31.92%45.90%52.78%
Operating Profit Margin
33.86%29.35%33.38%28.32%-17.48%-10.91%33.70%33.38%
Pretax Profit Margin
33.38%29.04%32.89%28.50%-19.88%-11.91%32.89%32.89%
Net Profit Margin
26.66%22.72%24.61%23.59%-21.76%-19.07%24.61%24.61%
Effective Tax Rate
20.12%21.77%25.16%17.24%-9.42%-60.09%25.16%25.16%
Return on Assets
27.07%42.33%26.23%16.13%-14.67%-11.56%12.69%16.13%
Return On Equity
78.52%60.97%36.33%19.20%-18.81%-15.58%13.91%19.20%
Return on Capital Employed
99.73%78.75%49.28%23.05%-15.11%-8.92%22.28%23.05%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A3.16N/A
Quick Ratio
0.751.762.674.283.002.432.594.28
Cash ratio
0.330.581.250.720.430.380.430.72
Days of Sales Outstanding
97.7670.52129.24120.27138.05121.21180.50129.24
Days of Inventory outstanding
196.2248.1541.8839.6744.1255.4848.4841.88
Operating Cycle
293.98118.68171.12159.94182.18176.6992.99159.94
Days of Payables Outstanding
70.9935.6659.1385.5561.5076.0967.5859.13
Cash Conversion Cycle
222.9883.01111.9974.38120.68100.59124.87111.99
Debt Ratios
Debt Ratio
0.090.140.090.060.060.100.210.09
Debt Equity Ratio
0.270.200.120.070.080.130.280.12
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.210.160.110.060.070.12N/A0.06
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A83.62N/A
Cash Flow to Debt Ratio
1.705.232.31-0.47-0.330.20N/AN/A
Company Equity Multiplier
2.901.441.381.191.281.341.281.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.150.390.19-0.04-0.030.030.190.19
Free Cash Flow / Operating Cash Flow Ratio
0.960.990.997.581.070.960.997.58
Cash Flow Coverage Ratio
1.705.232.31-0.47-0.330.20N/AN/A
Short Term Coverage Ratio
1.705.232.31-0.47-0.330.201.551.55
Dividend Payout Ratio
40.24%211.94%N/AN/AN/AN/AN/AN/A